Barbarosh Craig A.'s Form 4 filing
Nextgen Healthcare, Inc. (NXGN) · filed Nov 4, 2021
- Accession no.
- 0001209191-21-062955
- Filed
- Nov 4, 2021
- Trade date
- Nov 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $148.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barbarosh Craig A.CIK 0001472457 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Common Stock | SSaleDisposed | −9,000 | $16.54F2 | −$148,860 | 63,946 | Direct | |
| Nov 2, 2021 | Common Stock | AGrant or awardAcquired | +14,237 | $0.00 | $0 | 78,183 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.345 to $16.69. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Referenced by the price of 1 transaction in Table I.